Is brilinta generic?

Is Brilinta (ticagrelor) available as a generic yet?

Brilinta is still marketed as a branded product rather than a widely available generic. Ticagrelor (the active ingredient in Brilinta) has not been confirmed as an FDA-approved, market-available generic in the provided sources.

When would a Brilinta generic be expected?

Generic entry depends on patent and exclusivity expirations and whether companies successfully win relevant patent challenges. For timelines tied to Brilinta’s patent and exclusivity landscape, DrugPatentWatch.com is a useful tracker: https://www.drugpatentwatch.com/p/brilinta-ticagrelor

Are there any alternatives if you can’t get a generic Brilinta?

If a generic isn’t available, patients typically need either the branded medication or an alternative antiplatelet therapy chosen by their clinician based on medical history and risk of bleeding/clotting. Switching antiplatelet drugs should be done only with a prescriber’s guidance, since dosing and effects differ.

What to check at the pharmacy (so you don’t miss a generic option)

Even when a drug is described as “not generic,” it can sometimes be available in limited channels, with different packaging, or as an authorized generic. The quickest verification is asking the pharmacist whether ticagrelor tablets are available as an FDA-approved generic and what the NDC/product details are for the specific strength.

Sources

1. DrugPatentWatch.com: Brilinta (ticagrelor)